Staff

H. Vondeling

Professor Health Technology Assessment

 

 

 

Address

Hindrik Vondeling

 

Department of Health Economic.

 

Centre for Applied Health Services Research

 

and Technology Assessment (CAST)

 

At University of Southern Denmark

 

 

 

 

 

 

 

Background

Biologist with a specialization in animal physiology and behavior.

Introduction to the general framework for technology assessment as part of the first-year teaching program in sociology, University of Groningen. Introduction to environmental impact assessment as part of a doctoral course in environmental sciences, University of Groningen.

Research interests

Innovation in health care, technological change, technology foresight, methods for early warning of emerging and new health technologies, constructive technology assessment, technology transfer, health technology assessment in developing countries, pharmacoeconomics, economic evaluation of health care programmes, diffusion of health technology, priority setting for health technology assessment, priority setting in health care, health policy analysis, integrated care, laser applications in medicine, minimally invasive surgery, diabetes mellitus, public health genomics

Curriculum Vitae

Education

1988 M.Sc. Biology

University of Groningen, the Netherlands

1998 PhD (Medical Faculty). Title: Let there be

light. Towards rational use of lasers in

medicine. Maastricht University, the

Netherlands.

Professional experience

Current position

2011- Professor in Health Technology Assessment (HTA) at the Department of Health Economics and at the Centre for Applied Health Services Research and Technology Assessment (CAST), University of Southern Denmark, Odense, Denmark

Previous positions

2009-2011 Professor in Health Economics and Health Services Research at the Department of Health Technology and Services Research, Faculty of Management and Business, Twente University, Enschede, the Netherlands

2002-2009 Associate Professor in Health Technology Assessment (HTA) at the Department of Health Economics and at the Centre for Applied Health Services Research and Technology Assessment (CAST), University of Southern Denmark, Odense, Denmark

1999-2002 Assistant Professor in HTA at the Department of Health Economics and at CAST, University of Southern Denmark, Odense, Denmark

1993-1998 Researcher in HTA at the Department of Epidemiology and Biostatistics and the Institute for Research in Extramural Medicine (EMGO-Institute)

Vrije Universiteit Amsterdam, the

Netherlands

1993-1994 Teacher at the Department of Health Economics, Maastricht University, the Netherlands

1988-1993 Junior Researcher at the Institute for Medical Technology Assessment and the Department of Health Economics, Maastricht University, the Netherlands

Networks

Health Technology Assessment international (HTAi), International Health Economics Association (iHEA)

Other activities

·

Reviewing research proposals for scientific councils in the Netherlands, England and Denmark

·

Reviewing manuscripts for various international journals

·

Member of the Editorial Board of three international journals

Publications

Vondeling H. Economic evaluation of integrated care. An introduction. International Journal of Integrated Care 2004(4). (Published online at URL:http://www.ijic.org/).

Vondeling H, Iversen P.B. Reimbursement of glitazones in treatment of type 2 diabetes patients in Denmark in the context of a voluntary system for submitting pharmacoeconomic studies. The European Journal of Health Economics 2004 (5)3:263-69.

Douw K, Vondeling H, Sorensen J, Jorgensen T, Sigmund H. The future should not take us by surprise: preparation of an Early Warning System in Denmark. International Journal of Technology Assessment in Health Care 2004 (20):342-350.

Åbom B, Kragstrup J, Vondeling H, Bakketeig L, Støvring H. Place of death influenced by cancer patients’ contact to their general practitioner. British Journal of General Practice 2005(55):684-9.

Åbom B, Kragstrup J, Vondeling H, Støvring H, Bakketeig L. Defining cancer patients as being in the terminal phase: who receives a formal diagnosis and what are the effects? Journal of Clinical Oncology 2005(23)30:7411-16.

Andreasen L, Vondeling H. Prostata specifikt antigen i diagnostikken af prostatacancer i Danmark (Prostate specific antigen in diagnosis of prostate cancer in Denmark). Ugeskrift for Læger 2006(168)5:475-7 (in Danish).

Douw K, Vondeling H, Oortwijn W. Priority setting for horizon scanning of new health technologies in Denmark: Views of health care stakeholders and health economists. Health Policy 2006(76)3:334-345.

Douw K, Vondeling H. Setting priorities for assessment of new health technologies: an international survey of Horizon Scanning Systems. International Journal of Technology Assessment in Health Care 2006(22)2:177-183.

Åbom B, Kragstrup J, Støvring H, Vondeling H, Bakketeig L. Place of death influenced by cancer patients’ contact to their general practitioner. British Journal of General Practice 2005(55):684-689.

Åbom B, Kragstrup J, Vondeling H, Støvring H, Bakketeig L. Defining cancer patients as being in the terminal phase: who receives a formal diagnosis and what are the effects? Journal of Clinical Oncology 2005(23)30:7411-16.

Åbom B, Kragstrup J, Vondeling H, Støvring H, Bakketeig LS. Does persistent involvement by the GP improve palliative care at home for end-stage cancer patients? Palliative Medicine 2006(20)5:507-12.

Andreasen L, Vondeling H. Prostata specifikt antigen i diagnostikken af prostatacancer i Danmark (Prostate specific antigen in diagnosis of prostate cancer in Denmark). Ugeskrift for Læger 2006(168)5:475-7 (in Danish).

Douw K, Vondeling H, Oortwijn W. Priority setting for horizon scanning of new health technologies in Denmark: Views of health care stakeholders and health economists. Health Policy 2006(76)3:334-345.

Douw K, Vondeling H. Setting priorities for assessment of new health technologies: an international survey of Horizon Scanning Systems. International Journal of Technology Assessment in Health Care 2006(22)2:177-183.

Åbom B, Kragstrup J, Vondeling H, Støvring H, Bakketeig LS. Does persistent involvement by the GP improve palliative care at home for end-stage cancer patients? Palliative Medicine 2006(20)5:507-12.

Iversen P, Vondeling H. Reimbursement decision making and prescription patterns of glitazones in treatment of type 2 diabetes mellitus patients in Denmark. Health Care Analysis 2006(14):79-89.

Douw K, Vondeling H. Informing the selection of new health technologies for evaluation: can clinical experts predict which new anticancer drugs will impact health care in Denmark? Social Science and Medicine 2007(64):283-6.

Thygesen M, Vondeling H, Douw K, Jønler M, Pedersen KV, Mommsen S. Udvikling af en internetsøgestrategi til identification af ny medicinsk teknologi inden for prostatacancer (Development of an Internet search strategy for identification of new health technology in the field of prostate cancer). Ugeskrift for Læger 2007(169)20:1912-6 (in Danish)

Linden L, Vondeling H, Packer C, Cook A. Does the National institute for Health and Clinical Excellence only appraise new pharmaceuticals? International Journal of Technology Assessment in Health Care 2007(23)3:349-53.

Xuanqian X, Vondeling H. Cost-utility analysis of intensive blood-glucose control with metformin versus usual care in overweight type 2 diabetes mellitus patients in Beijing; P.R. China. Value in Health 2008(11)S1:S23-S32.

Hjulmann K, Vondeling H, Bech M. Why did some Danish counties introduce breast cancer screening and others not? An exploratory study of four selected counties. International Journal of Technology Assessment in Health Care 2008(24)3:326-332.